Preview Mode Links will not work in preview mode

Apr 9, 2020

Proceedings from the Second Annual Miami General Medical Oncology Symposium — Part 7: Breast Cancer. Featuring perspectives from Drs Harold J Burstein, Charles E Geyer Jr, Erika Hamilton and Virginia Kaklamani.

  • ER-Positive, HER2-Negative Breast Cancer
    • First-Line Endocrine Treatment for HR-Positive, HER2-Negative Metastatic Breast Cancer — Dr Hamilton
    • Treatment of Metastatic Breast Cancer Progressing on a CDK4/6 Inhibitor — Dr Kaklamani
  • HER2-Positive and Triple-Negative Breast Cancer
    • New Agents in HER2-Positive Metastatic Breast Cancer — Dr Geyer
    • Checkpoint Inhibitors in Breast Cancer in the Metastatic and Neoadjuvant Setting — Dr Burstein

CME information and select publications